Physician
Upper Chesapeake Medical Center, INC.
Upper Chesapeake Medical Center, INC. was paid $1.57M by Medicaid between Jan 2018 and Nov 2024, across 79 billing codes. Its largest line is G0378, Hospital observation service, per hour — 38% of everything it billed.
33Billing provider infoUPPER CHESAPEAKE MEDICAL CENTER, INC.
BEL AIR, MD 21014
BEL AIR, MD 21014
33aNPI1598761355assigned 06/24/2005
33bProvider typePsychiatry Physician
28Total paid$1.57M
24GClaims72,259
24DCodes billed79
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Psychiatry Physician providers in Maryland
Rank by total paid#13 of 229
Median peer was paid$82K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRIOLO, MARCUS controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,601 | $81K | |
| 2019 | 14,157 | $236K | |
| 2020 | 7,588 | $225K | |
| 2021 | 9,700 | $319K | |
| 2022 | 9,563 | $286K | |
| 2023 | 7,756 | $199K | |
| 2024incomplete | 7,894 | $226K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 38% | 1,232 | 1,090 | $597K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 4,862 | 4,347 | $416K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 2,044 | 1,871 | $145K |
| 41899 | Unlisted procedure, dentoalveolar structures | 8.3% | 72 | 71 | $130K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 683 | 614 | $112K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.8% | 3,469 | 2,905 | $91K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 204 | 130 | $25K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 100 | 94 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,598 | 1,478 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 217 | 206 | $6K |
| 93793 | <1% | 818 | 576 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,909 | 1,423 | $5K |
67 more codes
| 80053 | Comprehensive metabolic panel | <1% | 6,788 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,443 | $4K |
| 97597 | <1% | 120 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,419 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 913 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,239 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 391 | $1K |
| 84484 | <1% | 2,705 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 78 | $916.39 |
| 71045 | Radiologic examination, chest; single view | <1% | 2,031 | $834.78 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 201 | $788.73 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 160 | $702.19 |
| 81001 | <1% | 1,759 | $450.91 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 121 | $394.66 |
| 83735 | <1% | 3,987 | $390.83 | |
| 83690 | <1% | 1,738 | $315.43 | |
| 85610 | <1% | 3,552 | $293.30 | |
| 82150 | <1% | 586 | $292.68 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 152 | $282.28 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 656 | $244.30 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,174 | $209.07 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 579 | $197.22 |
| A6196 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing | <1% | 980 | $134.41 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 465 | $129.72 |
| 81003 | <1% | 807 | $112.80 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 293 | $105.33 |
| 84703 | <1% | 718 | $98.47 | |
| 80061 | Lipid panel | <1% | 232 | $91.90 |
| 85730 | <1% | 394 | $69.88 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,977 | $56.39 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 12 | $42.65 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 999 | $42.27 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,173 | $39.23 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 182 | $32.39 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 433 | $19.59 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 264 | $17.80 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 301 | $17.28 |
| 85027 | <1% | 53 | $14.83 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,735 | $13.92 |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 628 | $13.08 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 170 | $12.59 |
| 83605 | <1% | 58 | $11.01 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 421 | $6.16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 166 | $3.75 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $3.24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 71 | $0.23 |
| J2704 | Injection, propofol, 10 mg | <1% | 483 | $0.15 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 20 | $0.00 |
| 71275 | Computed tomographic angiography, chest, with contrast material | 0% | 24 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 48 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 43 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 15 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 26 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 42 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 40 | $0.00 |
| 87040 | 0% | 27 | $0.00 | |
| 86850 | 0% | 14 | $0.00 | |
| 83880 | 0% | 12 | $0.00 | |
| 86901 | 0% | 14 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 575 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 1,053 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 53 | $0.00 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 25 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 54 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
| 86900 | 0% | 14 | $0.00 | |
| J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRIOLO, MARCUS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upper Chesapeake Medical Services, INC | Bel Air, MD | $2.91M |
| Harford Memorial Hospital, INC. | Havre De Grace, MD | $2.03M |
| Harford Primary Care LLC | Bel Air, MD | $880K |
| Upper Chesapeake Cardiology, LLC | Bel Air, MD | $565K |
| Upper Chesapeake Primary Care,llc | Bel Air, MD | $480K |
| Upper Chesapeake Womens Care, LLC | Bel Air, MD | $459K |
| Upper Chesapeake Medical Services, INC. | Aberdeen, MD | $363K |
| Upper Chesapeake Hematology and Oncology Services, LLC | Bel Air, MD | $184K |
| Harford Crisis Center, INC. | Bel Air, MD | $116K |
| Upper Chesapeake Endocrinology Associates, LLC | Aberdeen, MD | $106K |
| Upper Chesapeake Orthopedics, LLC | Bel Air, MD | $75K |
| Upper Chesapeake Surgical Associates, LLC | Bel Air, MD | $53K |
| Upper Chesapeake Critical Care Associates, LLC | Bel Air, MD | $52K |
| Harford Crisis Center, INC. | Bel Air, MD | $37K |
| Upper Chesapeake Radiation Oncology, LLC | Aberdeen, MD | $11K |
| Upper Chesapeake Medical Center, INC. | Aberdeen, MD | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.